Caplin M - Search Results

1

Role of interferon-alpha in patients with neuroendocrine tumors: a retrospective study.

Mirvis E, Mandair D, Garcia-Hernandez J, Mohmaduvesh M, Toumpanakis C, Caplin M. Mirvis E, et al. Among authors: caplin m. Anticancer Res. 2014 Nov;34(11):6601-7. Anticancer Res. 2014. PMID: 25368264

2

Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumours.

Caplin ME, Mielcarek W, Buscombe JR, Jones AL, Croasdale PL, Cooper MS, Burroughs AK, Hilson AW. Caplin ME, et al. Nucl Med Commun. 2000 Jan;21(1):97-102. doi: 10.1097/00006231-200001000-00016. Nucl Med Commun. 2000. PMID: 10717909 Clinical Trial.

3

Long-term efficacy of high-activity 111in-pentetreotide therapy in patients with disseminated neuroendocrine tumors.

Buscombe JR, Caplin ME, Hilson AJ. Buscombe JR, et al. J Nucl Med. 2003 Jan;44(1):1-6. J Nucl Med. 2003. PMID: 12515868 Free article. Clinical Trial.

4

Prediction of clinical outcome in treated neuroendocrine tumours of carcinoid type using functional volumes on 111In-pentetreotide SPECT imaging.

Gopinath G, Ahmed A, Buscombe JR, Dickson JC, Caplin ME, Hilson AJ. Gopinath G, et al. Nucl Med Commun. 2004 Mar;25(3):253-7. doi: 10.1097/00006231-200403000-00007. Nucl Med Commun. 2004. PMID: 15094443

5

Endocrine tumours of the gastrointestinal tract. Biotherapy for metastatic endocrine tumours.

Shah T, Caplin M. Shah T, et al. Among authors: caplin m. Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):617-36. doi: 10.1016/j.bpg.2005.02.012. Best Pract Res Clin Gastroenterol. 2005. PMID: 16183531 Review.

6

Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy.

McStay MK, Maudgil D, Williams M, Tibballs JM, Watkinson AF, Caplin ME, Buscombe JR. McStay MK, et al. Among authors: caplin me. Radiology. 2005 Nov;237(2):718-26. doi: 10.1148/radiol.2372041203. Epub 2005 Sep 28. Radiology. 2005. PMID: 16192318

7

Long-term efficacy of low activity meta-[131I]iodobenzylguanidine therapy in patients with disseminated neuroendocrine tumours depends on initial response.

Buscombe JR, Cwikla JB, Caplin ME, Hilson AJ. Buscombe JR, et al. Nucl Med Commun. 2005 Nov;26(11):969-76. doi: 10.1097/01.mnm.0000184941.06123.b9. Nucl Med Commun. 2005. PMID: 16208174

8

Goblet cell carcinoid tumors (adenocarcinoid) of the appendix.

Toumpanakis C, Standish RA, Baishnab E, Winslet MC, Caplin ME. Toumpanakis C, et al. Dis Colon Rectum. 2007 Mar;50(3):315-22. doi: 10.1007/s10350-006-0762-4. Dis Colon Rectum. 2007. PMID: 17195086

9

Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.

Toumpanakis C, Meyer T, Caplin ME. Toumpanakis C, et al. Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):131-44. doi: 10.1016/j.beem.2007.01.005. Best Pract Res Clin Endocrinol Metab. 2007. PMID: 17382269 Review.

10

Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century.

Bhattacharyya S, Toumpanakis C, Caplin ME, Davar J. Bhattacharyya S, et al. Am J Cardiol. 2008 Feb 1;101(3):378-81. doi: 10.1016/j.amjcard.2007.08.045. Epub 2007 Dec 21. Am J Cardiol. 2008. PMID: 18237604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters